Kory Wentworth
Financieel Directeur/CFO bij ENTRADA THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Kory Wentworth
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-11-2020 | - |
| Treasurer | 01-11-2020 | - |
Loopbaan van Kory Wentworth
Eerdere bekende functies van Kory Wentworth
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18-12-2017 | 08-09-2020 |
| Treasurer | 18-12-2017 | 02-10-2020 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-11-2017 | 01-12-2017 |
| Directeur/Bestuurslid | 01-01-2012 | 01-12-2017 | |
| Corporate Officer/Principal | 01-12-2008 | 01-12-2017 |
Opleiding van Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Kory Wentworth
- Ervaring
